Searched for
JIANGSU ALPHAMAB
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Glenmark to focus on becoming branded company, says Glenn SaldanhaGlenmark Pharmaceuticals, having navigated recent challenges, is shifting its focus to branded products for higher profit margins. The comp...
- Glenmark inks licensing pact with Jiangsu Alphamab, 3D Medicines for cancer drugGlenmark Pharmaceuticals Ltd announced that its subsidiary, Glenmark Specialty S A (GSSA), has entered into a license agreement with Jiangs...
- Load More